TK216 in Patients With Relapsed or Refractory Ewing Sarcoma
Clinical trial NCT02657005 · TERMINATED
Trial details
- NCT number
- NCT02657005
- Sponsor
- Oncternal Therapeutics, Inc
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-01
- Primary completion
- 2022-05-01
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.